Celltrion Sells U.S. Subsidiary to Celltrion Healthcare
[Asia Economy Reporter Lee Jung-yoon] Celltrion announced on the 5th that it will dispose of 100% of the shares owned by its U.S. subsidiary, Celltrion USA Inc., to its affiliate Celltrion Healthcare.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
The number of shares to be disposed of is 3,050, and the disposal amount is 17.55 billion KRW. The company stated that the purpose of the disposal is "to focus on core competencies among affiliates and to strengthen expertise in pharmaceutical sales in the United States."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
